Evaluation of the Noga System: Detecting of Respiratory Related Sleep Disorders in Cardiac Patients
NCT ID: NCT00800397
Last Updated: 2009-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2007-12-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prevalence and Risk Factors of Sleep Disordered Breathing in a Heart Failure Program
NCT00679822
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
NCT00566137
Validation of a New Algorithm for Screening Sleep Apnea Syndrome From Electrocardiogram
NCT04759482
Rapid Eye Movement Related OSA in Diabetic Versus Non-Diabetic Patients Treated With PCI
NCT03479788
Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor
NCT03149744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who is willing and able to tolerate a full night Polysomnography
3. Patient is not receiving oxygen treatment
4. Patients is 18 years of age or above
5. Patient is able and willing to sign the institution human subjects committee approved Informed Consent Form.
Exclusion Criteria
2. Patient is receiving oxygen.
3. Participation in a clinical trial within the last 60 days and during the study.
4. Life expectancy \< 1 month.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
WideMed LTD.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
WideMed LTD.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Morristown memorial hospital
Morristown, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MorpheusHx002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.